Hidden kidney disease: 3000 patients to be screened in major czech study
NCT ID NCT07153432
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This observational study will screen 3000 adults at a Czech hospital to find how many have chronic kidney disease, especially those who don't know it yet. Participants must be over 50, or over 18 with conditions like diabetes or high blood pressure. The study does not test any treatment, but aims to improve early detection.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal how many people with risk factors have undiagnosed kidney disease, pointing to better screening strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not test any intervention, so it cannot directly improve health outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2025
- Expected to finish
-
Jan 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients followed at the Institute for Clinical and Experimental Medicine
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age \> 50 or age \>18 + one of these conditions (history of diabetes, arterial hypertension, ischemic heart disease, stroke, perpheral artery disease, atrial fibrillation, heart failure) * agree to participate * followed at the Institute for Clinical and Experimental Medicine Exclusion Criteria: * unwilling to participate * kidney transplant recipient/previous kidney transplantation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic kidney diseases are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Institute for Clinical and Experimental Medicine
RECRUITINGPrague, 14021, Czechia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a nurse and a neighbor help tame chronic disease?
- Which SGLT2 inhibitor wins? trial pits empagliflozin against dapagliflozin
- Does better dialysis keep parathyroid hormone in check?
- Biobank aims to unlock the mysteries of calciphylaxis
- Do kidney patients know why a fistula matters before dialysis?
- Potassium binder may let kidney patients keep Life-Saving heart drugs